T he rate of obesity has dramatically increased since the 1970s and is the second leading preventive cause of death in the United States. 1 In 2014 alone, the US weight loss market totaled $64 billion, with approximately 20% of adults attempting weight loss through various diets. 2 One such diet, the low-carbohydrate diet (LCD), was advocated as early as 1869 in William Banting's Letter on Corpulence. 3 The LCD regained popularity with the 1972 publication of Dr. Atkins' Diet Revolution: The High Calorie Way to Stay Thin Forever. 4 Notably, Atkins did not publish safety or efficacy findings in a peer-reviewed, scientific journal. Since then, many variations of LCDs have been popularized.
The public is likely confused about dietary recommendations and restrictions because of changing guidelines. The 2015 revised US Department of Agriculture Dietary Guidelines adjusted some long-held tenets of healthful eating, including the removal of the cholesterol intake limitation (previously, 300 mg/d). 5, 6 The low-fat philosophy of the past several decades has been called into question, with publications included in a meta-analysis 7 dismissing the link between saturated fat intake and cardiovascular disease. Patients might change their diets based on these new guidelines and reports and increase their consumption of red or processed meats, for example, despite the consistent, unchanged recommendation to limit these foods. 5 Notwithstanding, a high intake of red meat, especially processed meat, is associated with increased cardiovascular and all-cause mortality [8] [9] [10] and is recognized as carcinogenic. 11 In this review, we analyzed LCDs, which are inherently higher in cholesterol, saturated fats, and animal products, to assess their effects on weight loss, glucose metabolism, blood pressure, and lipid levels.
Clinical Question: Are low-carbohydrate diets (LCDs) safe and effective for weight loss and cardiovascular and metabolic health?
Evidence: In the short-term, LCDs may be slightly better than low-fat diets for weight and triglycerides management but not superior for the management of blood glucose, blood pressure, or cholesterol levels. 
CLINICAL REVIEW

Effect of LCDs on Health
Weight Loss
Forty-one trials that evaluated the effects of LCDs on weight loss were reviewed. Two meta-analyses demonstrated greater weight loss with LCDs compared with LFDs at 6 months, but they had comparable weight loss results at 12 months. 14, 15 In a third meta-analysis of longterm (at least 1 year) weight loss, LCDs had a statistically significant 1.15-kg weighted mean difference compared with LFDs. 16 In addition, a 2-year, prospective RCT 17 of overweight or obese, mostly male (86%), middle-aged participants reported a 4.7-kg vs 2.9-kg weight loss with a non-calorierestricted LCD compared with a calorie-restricted LFD, respectively. Further, at the 2-year conclusion, a 5.5-kg mean weight loss was found in participants who still adhered to the diets compared with 3.3 kg in those who had not adhered to the diets. 17 Greater weight loss may be promoted by VLCKDs than by moderate LCDs. When carbohydrate intake was restricted to 10% of total calories, a meta-analysis of 13 trials found a weighted mean difference weight loss of 0.91 kg with VLCKDs at end points of 12 months or longer compared with LFDs. The clinical significance of this small weight loss is questionable, and adherence to VLCKDs beyond 6 months is nearly nonexistent. 18 Compared with LFDs, LCDs have not been shown to result in greater long-term weight loss in people with type 2 diabetes mellitus. In a large trial 19 restricted to tosis and rapid weight loss, followed by a subsequent lessrestrictive phase. The lack of a consistent definition makes comparison among LCDs difficult.
Review of the Literature
Our literature search was originally designed to find articles that addressed potential adverse effects and overall safety of LCDs. We used the Ovid MEDLINE online database, searching January 2005 through April 2016
with key search terms: Atkins, diet, ketogenic diet, ketosis, low carbohydrate, nutrition, risk, paleo, safe, South Beach, and Zone. We limited our search to RCTs, meta-analyses, and systematic reviews in English. After duplicates were removed, the titles and abstracts of 72 articles were screened to identify potentially eligible studies for subsequent full review.
The majority of the articles addressed implications of LCDs in weight loss or obesity and cardiovascular parameters, such as glucose metabolism, blood pressure, and cholesterol levels, which became the focus of our review. Nonhuman studies, non-English studies, and observational studies were excluded. Studies that did not specifically address weight loss, glucose metabolism, blood pressure, or cholesterol were also excluded, as were studies involving pediatric or pregnant populations. We did not exclude studies on the basis of trial length or number of participants. References of the included studies were scanned, and pertinent articles were added to the review.
The Evidence
Included studies were RCTs of either parallel or crossover design and systematic reviews. The majority of studies required participants to be overweight or obese, often with 1 cardiovascular risk factor, but some studies had healthy adult samples. The number of participants in the trials ranged from 9 to several hundred. The authors defined LCDs according to carbohydrate restriction, which ranged from 4% of total calories (<20 g) to 46%. Twenty-nine trials that evaluated the effects of LCDs on blood pressure were reviewed. Studies that compared more than 2 types of diets (eg, LCD vs LFD vs Mediterranean diet) were separated into individual components for a total of 38 comparisons. More than half of the comparisons (63%) showed a statistically significant improvement in blood pressure from baseline (systolic, diastolic, or both) with both the LCD and comparison diets. Most (76%) showed no statistically significant difference in participants' blood pressure between the diets at the end of the studies. This finding is consistent with the meta-analysis by Bueno et al, 18 which found no difference in systolic blood pressure between VLCKD and overweight adults with a diagnosis of type 2 diabetes mellitus for at least 6 months, the LCD resulted in a faster weight loss at 3 months compared with the LFD, but at 12 months, both groups had lost a mean of 3.1 kg. 19 The effects of LCDs may be different in women. An 24, 25 but several showed no difference from the comparison diet. 22, [24] [25] [26] [27] [28] One study with a VLCKD group 22 demonstrated decreased need for pharmacotherapy.
Cholesterol and Triglyceride Levels
Forty-four trials that evaluated lipids, including triglyceride, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and total cholesterol levels had mixed results. Trials that compared more than 2 diets were separated into individual components for clarity. Triglycerides were evaluated in 50 comparisons. An LCD was favored in 48% of the comparisons, the comparison diet in 4%, and 48% showed no statistically significant difference between the 2 diets. Three systematic reviews 12, 15, 18 favored the LCDs or VLCKDs in lowering triglycerides.
In 53 trial comparisons of HDL, LDL, and total cholesterol levels, 43% showed no difference between the 2 diets, 6% favored LCDs, 6% favored the comparison diet, and 45% had discordant results (sometimes LCD improved HDL but not LDL or total cholesterol levels).
However, the 3 systematic reviews 12,15,18 showed discordant results for nontriglyceride lipids.
Discussion
Low-carbohydrate diets may be appealing to patients because of their simplicity and lack of calorie restric- 8, [29] [30] [31] One main concern is that certain meats have been implicated in worsened all-cause mortality [8] [9] [10] and increased cancer risk, 11 
